grants_govPAR-25-324
Open
Method to Extend Research in Time (MERIT) Award Extension Request (Type 4 eSubmission Clinical Trial Optional)
- Response deadline
- Sep 7, 2028 Due in 681 days
- Date posted
- Jan 6, 2025
- Source
- Open notice
Description
The National Cancer Institute (NCI) Method to Extend Research in Time (MERIT) (R37) Award provides extended grant support to Early Stage Investigators (ESIs). By providing such an opportunity for longer term support to ESIs, the NCI intends to offer flexibility and opportunity for creativity and innovation and additional time to successfully launch their careers and to become more established before having to submit renewal applications (NOT-CA-18-037). The objective of the NCI's ESI MERIT Award is to allow eligible investigators the opportunity to obtain up to 7 years of support in two segments:
Classifications
- NAICS93.393
Documents (1)
- DownloadPAR-25-324-Full-Announcement.htmltext/html422 B
Contacts
- grantsinfo@nih.gov301-402-2541
Similar contracts
- Pancreatic Cancer Detection Consortium: Research Units (U01 Clinical Trial Optional)Due Nov 5, 2029
- Pancreatic Cancer Detection Consortium: Management and Data Coordination Unit (U24 Clinical Trial Not Allowed)Due May 25, 2027
- NCI Community Oncology Research Program (NCORP) Research Bases (UG1 Clinical Trial Required)Due Sep 18, 2026
- Research Opportunities in Cancer Epidemiology Cohort Studies (U01 Clinical Trial Not Allowed)Due Jul 5, 2029
- Integrating Biospecimen Science Approaches into Clinical Assay Development (U01 Clinical Trial Not Allowed)Due Sep 10, 2027
- Utilizing the PLCO Biospecimens Resource to Bridge Gaps in Cancer Etiology and Early Detection Research (U01 Clinical Trial Not Allowed)Due Oct 8, 2027